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Abstract
Background: Yersinia pestis is the causative agent of pneumonic plague; recently, we and others reported that during 
the first 24-36 hours after pulmonary infection with Y. pestis pro-inflammatory cytokine expression is undetectable in 
lung tissues.
Results: Here, we report that, intranasal infection of mice with CO92 delta yopH mutant results in an early pro-
inflammatory response in the lungs characterized by an increase in the pro-inflammatory cytokines Tumor Necrosis 
Factor-alpha and Interleukin one-beta 24 hours post-infection. CO92 delta yopH colonizes the lung but does not 
disseminate to the liver or spleen and is cleared from the host within 72 hours post-infection. This is different from what 
is observed in a wild-type CO92 infection, where pro-inflammatory cytokine expression and immune cell infiltration 
into the lungs is not detectable until 36-48 h post-infection. CO92 rapidly disseminates to the liver and spleen resulting 
in high bacterial burdens in these tissues ultimately cumulating in death 72-94 h post-infection. Mice deficient in TNF-
alpha are more susceptible to CO92 delta yopH infection with 40% of the mice succumbing to infection.
Conclusions: Altogether, our results suggest that YopH can inhibit an early pro-inflammatory response in the lungs of 
mice and that this is an important step in the pathogenesis of infection.
Background
Yersinia pestis is a Gram-negative bacterium with a
zoonotic life cycle that occasionally results in human
infections leading to plague [1]. Plague manifests in two
major forms, the most common being bubonic plague.
Bubonic plague is transmitted to humans through the
bite of an infected flea, resulting in intradermal inocula-
tion of the bacterium, which progresses to form the char-
acteristic lymphadenitis (bubos) of plague [1]. The less
common but contagious form of the disease is pneu-
monic plague, which is a severe pneumonia resulting
either from inhalation of infectious respiratory droplets,
or secondary to bubonic or septicemic plague. Pneu-
monic plague is highly aggressive and if untreated, is able
to kill the host within 2-4 days post-exposure, with mor-
tality rates that approach 100% [1-3].
We and others have begun to analyze the immune
response to primary pneumonic plague using wild-type
strains of Y. pestis in an effort to understand the interac-
tions of Y. pestis with its host [4,5]early during the devel-
opment of disease. The rapid progression of the disease
and associated mortality suggests that subversion of
innate immunity plays a key role in disease development
[4]. Our previous studies indicate a delay in the host
inflammatory response to infection, resulting in an
opportunity for the bacterium to replicate to high num-
bers and potentially overwhelm the host immune system,
rapidly resulting in death [4]. Modulation of host-
immune responses is a common pathogenic mechanism
among the virulent species of Yersinia  and much work
has been done to understand the molecular mechanisms
underlying the virulence factors involved in this process
[6-8].
The 70 Kb virulence plasmid (pCD-1), which is essen-
tial for virulence, contains all of the machinery and effec-
tor proteins for a type-three secretion system (TTSS)
[6,8]. The secreted effector proteins are also known as the
Yersinia outer proteins (Yops) and are transported from
the bacterial cytosol through the TTSS into the cyto-
plasm of a host cell to facilitate infection. All six of the
effector Yops have been studied, and at least one function
has been assigned to each based on in vitro studies. Sev-
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eral are involved in manipulating the host cytoskeleton
(YopE, YopH, YopT, YopO); these yops interfere with the
Rho family of GTPases and other host proteins involved
in the regulation of the cytoskeleton, and are therefore
important in the modulation of phagocytosis [9,10]. Oth-
ers are involved in the tempering of the host immune
response, in particular, YopH and YopJ, and to a lesser
extent, YopE and YopM have been shown to impact
inflammatory cytokine expression in vitro and in vivo
respectively [8,11].
YopH is a protein tyrosine phosphatase, which is
known to interact with p130cas and FAK to impair inva-
s i o n  o f  e p i t h e l i a l  c e l l s  b y  Yersinia pseudotuberculosis
[12,13]. YopH blocks cytoskeletal rearrangement upon
injection into the host cell, contributing to the decreased
ability of macrophages and other immune cells to phago-
cytose the bacteria [14]. Distinct from its ability to inter-
act with the cytoskeleton, YopH is also known to impact
host cell signaling by inactivation of the PI3K pathway
through unknown mechanisms [15]. The PI3K pathway
plays an important role in the macrophage response to
infection including generation of the oxidative burst and
nitric oxide production, phagosome formation, and has a
role in a negative regulation of IL-12 production, to help
keep the inflammatory response in check [16].
Numerous studies have determined that mutations in
YopH severely impact the virulence of the yersiniae [17-
19]. Recently we reported that CO92ΔyopH is severely
attenuated in both an intranasal and subcutaneous mod-
els of Y. pestis infection, which makes CO92ΔyopH a very
good live-attenuated vaccine strain [18]. The ability of
CO92ΔyopH to provide significant protection against vir-
ulent challenge suggests that a robust protective immune
response is generated during primary infection with this
strain. However, the role of YopH in the pathogenesis of
plague pneumonia or its impact on the immune response
in the lung has not been examined. In this study we test
the impact of the CO92ΔyopH mutant on both the viru-
lence and inflammatory response using a mouse model of
primary pneumonic plague.
Results
Y. pestis CO92ΔyopH is severely attenuated in an intranasal 
model of primary pneumonic plague
The survival of CD1 mice after IN infection with CO92 or
CO92ΔyopH  was determined and the survival curves
analyzed by log-rank analysis. Mice infected IN with ~107
CFU CO92ΔyopH  appeared normal at all time points
post infection and showed no outward signs of disease
whereas animals infected with ~104  CFU CO92 were
severely debilitated two days post-infection and suc-
cumbed to disease by day 4 post-infection (Figure 1).
Altogether, these data revealed that mice were able to
survive both intranasal and intradermal infection with
CO92ΔyopH at doses of ~107 CFU (Figure 1). Our results
indicate a significant difference in survival (p = 0.00001)
when CO92 is compared to CO92ΔyopH and that at the
highest dose tested (~107) CO92ΔyopH  is avirulent in
CD1 mice.
Attenuation of CO92ΔyopH is due to the loss of YopH and 
YopH enzymatic activity
We tested the ability of the CO92ΔyopH mutant comple-
mented with a wild type copy of the yopH gene to secrete
YopH in vitro. As shown in Figure 2A when the TTSS is
induced in vitro, the CO92ΔyopH mutant complemented
with yopH secretes similar levels of YopH into the culture
supernatant as CO92. Due to the YopH cleavage products
in secreted protein preparations, we also evaluated the
levels of YopH in whole cell extracts after induction. Sim-
i l a r  l e v e l s  o f  Y o p H  w e r e  d e t e c t e d  i n  t h e  w h o l e  c e l l
e x t r a cts  a n d  w e r e  c o n s is t e n t  wi t h  t h e  s ecr e t ed  p r o t e i n
profile (Figure 2B). To test if the attenuation phenotype of
CO92ΔyopH is linked to the yopH mutation, mice were
infected with the CO92ΔyopH  mutant carrying the
pAMC-1 complementing plasmid. Complementation of
YopH expressed from the pAMC-1 plasmid restores viru-
lence to the levels observed with CO92 carrying the
empty pCR2.1 plasmid (Figure 2C). However, virulence is
lost when the CO92ΔyopH mutant is complemented with
the YopH-C403A gene expressed from the pAMC-2 plas-
mid (Figure 2C). The C403A mutation abolishes the
YopH tyrosine phophatase activity, strongly suggesting
that the attenuation of the CO92ΔyopH mutant is due to
loss of the YopH phosphatase activity and these data are
consistent with previous studies of other Yersinia species
and attenuated Y. pestis strains which determined that
yopH mutants are highly attenuated [11,17,18,20,21].
Y. pestis CO92ΔyopH is able to persist in the lungs but does 
not spread systemically
The severe attenuation of Y. pestis CO92ΔyopH could be
due to an inability to colonize the lung, disseminate, or
replicate in the mouse. To further investigate the patho-
genesis of CO92ΔyopH, we determined the changes in
bacterial burdens over time. Mice were infected IN with
2×104  or 1×105  CFU  Y. pestis CO92 or CO92ΔyopH
respectively and sacrificed at the indicated times. Lungs,
livers, and spleens were processed as described in the
methods and dilutions plated to determine the CFU-bac-
teria/g tissue at each time point post-infection (24 h, 48 h,
72 h, 96 h). All of the mice infected with wild-type CO92
were dead by 72 hours post-infection making collection
of data at 72 h and beyond impossible for this group. Our
results suggest that CO92ΔyopH is able to persist in the
lungs through 48 h post-infection (Figure 3 and data not
shown). Bacterial burdens in the lungs of mice infected
with CO92 were significantly higher when compared toCantwell et al. BMC Immunology 2010, 11:29
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CO92ΔyopH at both 24 h and 48 h post-infection (p =
0.0002 for both time points, Mann-Whitney U test) (Fig-
ure 3). These data indicate that the CO92ΔyopH mutant
was unable to replicate at the site of infection. In addition,
we were unable to detect dissemination of the
CO92ΔyopH bacterium to the spleen or liver at any time
post-infection, while wild-type CO92 was present in the
livers and spleens in large numbers at 48 h post-infection
consistent with what we have reported previously [4].
Intranasal infection with CO92ΔyopH induces TNF-α and IL-
1β early during infection
In mouse models of primary pneumonic plague, mice
infected with CO92 do not mount an inflammatory
cytokine response until 36 h to 48 h post-infection [4,5].
Figure 1 CO92ΔyopH is attenuated by several routes of infection. A) 6-8 week old CD-1 mice were infected IN with 2 × 104 CFU of CO92 or 1 × 
107 CFU CO92ΔyopH. The mice were monitored for survival over a 10-day period. B) Mice were infected by intradermal injection with 2 × 104 CFU of 
CO92 or 1 × 107 CFU CO92ΔyopH and then monitored for survival. Data was analyzed by log-rank analysis and determined to be significant in both 
cases p = 0.00001. Data is representative of three independent experiments with 10/mice per experimental group.
Figure 2 YopH phosphatase activity is required for Y. pestis virulence. A) Complementation of the yopH mutation leads to similar levels of YopH 
expression in vitro. Various strains of Y. pestis were grown under type-three secretion system inducing conditions and then the supernatant was sub-
jected SDS-PAGE followed by immuno-blotting with rabbit-polyclonal anti-YopH antibodies. Immunoreactive protein bands were detected by en-
hanced chemiluminescence. Lanes: 1) molecular weight markers, 2&3) CO92, 4) CO92+pCR2.1, 5) CO92ΔyopH 6) CO92ΔyopH+ pAMC-1 (YopH). Note 
multiple bands are due to Pla mediated proteolysis. B) Whole cell extracts of cells grown under type-three secretion system inducing conditions. 
Lanes: 1) molecular weight markers, 2) CO92, 4) CO92+pCR2.1, 5) CO92ΔyopH 6) CO92ΔyopH+ pAMC-1 (YopH). C) Complementation of the yopH mu-
tation restores virulence in vivo. CD-1 mice were infected IN with 2 × 104 CFU of various Y. pestis strains. Mice infected IN with CO92 (υ) or CO92+pCR2.1 
(() succumbed rapidly to infection. Mice infected IN with CO92ΔyopH+pAMC-1 (σ), YopH, died with similar kinetics. However, mice infected IN with 
CO92ΔyopH+pAMC-2 ((), yopH-C403A, survived infection. Data is representative of two independent experiments with 10 mice/group.Cantwell et al. BMC Immunology 2010, 11:29
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We hypothesized that the attenuation of CO92ΔyopH
could be partially due to a strong inflammatory response
to the presence of the bacterium. Further, due to the
delayed arrival of neutrophils during plague pneumonia,
we suspected that TNF-α and IL-1β might be involved
[4,5]. To test this hypothesis, we measured the concentra-
tions of TNF-α and IL-1β in the bronchiolar alveolar
lavage fluid (BALF) after IN infection with CO92 or
CO92ΔyopH. Mice were infected with 2×104  CFU of
either Y. pestis CO92 or CO92ΔyopH and sacrificed 24 or
48 hours post-infection. BAL was performed on these
mice, and then ELISA analyzed the BALF for the concen-
tration of TNF-α and IL-1β. Mice infected with
CO92ΔyopH elicited a robust pro-inflammatory cytokine
response at 24 h post-infection, characterized by 349 ± 43
pg/ml of TNF-α and 461 ± 35 pg/ml of IL-1β in the BALF
of these mice 24 h post-infection (p = 0.001 in compari-
son to CO92). By 48 h post-infection the levels of both
cytokines had decreased but remained significant with
concentrations of TNF-α = 45 ± 12 pg/ml, and IL-1β =
104 ± 12 pg/ml (Figures 4A & 4B). BAL from mice
infected for 24 hours with wild-type CO92 had TNF-α
and IL-1β levels approximately equal to the levels in the
BALF from uninfected mice. However, at 48 h post-infec-
tion, both cytokines were detected in the BALF of these
mice with concentrations of TNF-α = 125 ± 19 pg/ml, and
IL-1β = 231 ± 21 pg/ml (Figures 4A &4B). The timing of
cytokine expression and the levels of cytokine induced
during a CO92 are consistent with what we have
observed previously [[4], and data not shown]. Alto-
gether, these data suggest that YopH is involved in delay-
ing or inhibiting the expression of TNF-α and IL-1β
during plague pneumonia and may be involved in the
overall delayed inflammatory response to this infection.
Mice lacking proinflammatory cytokines are more sensitive 
to CO92ΔyopH infection
If TNF-α and IL-1β were critical host-components lead-
ing to the attenuation observed in mice infected with
CO92ΔyopH, then it would not be unreasonable to pre-
dict that mice deficient in these molecules would be more
sensitive to infection with CO92ΔyopH. To test this
hypothesis, we used antibody mediated cytokine deple-
tion followed by IN challenge with CO92ΔyopH or CO92.
Briefly, mice were treated with monoclonal antibodies to
TNF-α, IL-1β, TNF-α+IL-1β, or the appropriate control
IgG one day prior to infection and then every third day
for the course of the infection as we have described previ-
ously [22]. Mice treated with IL-1β depleting antibodies
were not significantly more sensitive to CO92ΔyopH
infection than the control mice (Figure 5A) and only 10%
of the mice treated with the TNF-α depleting antibodies
succumbed to infection (Figure 5B). However, 30% of the
mice treated with both the IL-1β and the TNF-α deplet-
ing antibodies succumbed to CO92ΔyopH infection (Fig-
ure 5C). These data did not reach significance (p =
0.0675) but suggest that proinflammatory cytokines
expressed during CO92ΔyopH infection help control this
infection.
Because the site of the infection was the mucosal sur-
face of the nasal cavity and lung, it was possible that sys-
temically administered IgG poorly depletes cytokines at
this site. To test our hypothesis in another way, we
infected TNF-α deficient mice (TNF-α-/-) and control
mice (B6129SF2/J) with CO92ΔyopH or CO92. As pre-
dicted, the control mice and the TNF-α-/- mice rapidly
succumbed to infection with CO92. Consistent with what
was observed with out-bred CD1 mice, the B6129SF2/J
control mice were completely resistant to infection with
107 CFU of CO92ΔyopH (not shown and Figure 6). How-
ever, when the isogenic TNF-α-/- mice were infected with
2 × 104 CFU CO92ΔyopH, significantly (p = 0.0289), 40%
of the mice succumbed to infection within 5 days (Figure
6). Altogether, these data suggest that the CO92ΔyopH
mutant of Yersinia pestis is attenuated in multiple strains
of wild type mice including CD-1, B6129SF2/J, and
C57BL6/j but is partially virulent in mice lacking TNF-α
(this study and [4]). These data further suggest that YopH
mediated suppression of pulmonary TNF-α is an impor-
tant virulence promoting mechanism (Figures 3 and 4 as
well as data not shown).
Histopathology of CO92ΔyopHinfection
Recently, we and others described the development of
primary pneumonic plague in the mouse following infec-
Figure 3 Bacterial burdens in the Lungs. 6-8 week old female CD1 
mice were infected IN with 2×104-1×105 CFU of CO92 or CO92ΔyopH 
respectively. Mice were sacrificed at 24 h and 48 h post-infection and 
the lungs were weighed, crushed, and plated for CFU/g tissue. There is 
a significant difference in bacterial colonization of the lungs between 
wild type CO92 and CO92ΔyopH at both 24 h (*** p = 0.0002) and 48 h 
(***p = 0.0002) post-infection. These data are representative of two in-
dependent experiments with at least 6 mice per group. *** p = 0.0002, 
Mann-Whitney U test, CO92 infected lungs vs. CO92ΔyopH infected 
lungs at 24 h or 48 h post-infection, bar represents mean value.Cantwell et al. BMC Immunology 2010, 11:29
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tion with CO92 [4,5]. The most striking feature of pri-
mary plague pneumonia is a 36-hour delay in the
inflammatory response to infection, which is character-
ized by rapid increases in bacterial burden, a lack of
inflammatory cytokine and chemokine expression, and
scant evidence of inflammation in histopathological
examination of lung tissues. CO92ΔyopH infection pres-
ents a significantly different picture: 1) there is little bac-
terial replication in the lungs (Fig. 3), 2) CO92ΔyopH is
severely attenuated in both bubonic and pneumonic
plague models (Fig. 1A &1B and [18]), and 3) TNF-α and
IL-1β are readily detectable in the BALF of mice infected
with CO92ΔyopH  at 24 hours post-infection (Fig. 4A
&4B) suggesting that CO92ΔyopH induces a detectable
inflammatory response in the lung. Altogether, these data
would suggest that the histopathology of CO92ΔyopH
might be different than that observed during a CO92
infection.
To evaluate any differences in histopathology, CD1
m i c e  w e r e  i n f e c t e d  I N  w i t h  2  ×  1 0 4 CFU of CO92 or
CO92ΔyopH. Twenty-four and 48 h post-infection lungs
were harvested, fixed, embedded in paraffin, and stained
with hematoxylin and eosin. Tissues were examined for
inflammatory changes as we have described previously
[4,23-25]. Consistent with our previous findings, infec-
tion with CO92 for 24 h leads to very subtle changes
including congestion (Fig. 7B) and hyperplasia of the
bronchial epithelium (Fig. 7B) with little apparent tissue
damage. However, infection with CO92ΔyopH for 24 h
leads to wide spread vacuolization of the bronchial epi-
thelium (Fig. 7C, black arrows), and infiltration of the
parenchyma with inflammatory cells. All of the mice
infected with CO92ΔyopH had extensive vacuolization of
the bronchial epithelium as shown in figure 7C. Although
there is extensive damage to the bronchial epithelium, the
majority of conducting airways remain relatively clear of
debris with the exception of the occasional macrophage
in the lumen of the airways (Fig. 7C). Consistent with
what is seen with the wild-type infection at 24 h, the
lower airways and alveolar spaces of the CO92ΔyopH
infected animals were characterized by congestion (not
shown).
At 48 h post infection the histopathology of the
CO92ΔyopH infection remains very different than that
observed during a CO92 infection. The wild-type infec-
tion is characterized by large areas of pulmonary consoli-
dation (not shown), a robust inflammatory response
composed of mostly of PMNs (Fig. 7D, black arrow),
fibrin, exudates in conducting airways (Fig. 7D), and
abundant free bacteria (Fig. 7E, black arrow). The inflam-
matory response to the CO92 infection at 48 h post-
infection also includes multiple areas of overt extracellu-
lar bacterial growth interspersed with a large number of
dead host-cells and cellular debris. These findings were
observed in 100% of the mice infected with CO92 for 48
h. CO92ΔyopH exhibits several prominent findings at the
48 h time point (Fig. 7F-H). Large pronounced inflamma-
tory lesions composed mostly of PMNs were present in
50% of the mice investigated at this time point (Fig. 7G
and 7H). These lesions are different than those observed
in the wild-type infection in that bacterial growth is not
apparent (Fig. 7G), there is less cell death and cellular
debris (compare Fig. 7D and 7G), and there is a pro-
nounced infiltration of the bronchial mucosa with
inflammatory cells (Fig. 7H). The other type of lesion
common in the CO92ΔyopH infected mice is exemplified
in Figure 7F and consists of severe vacuolization of the
bronchial epithelium. In contrast to what is observed at
24 h (Fig. 7C), necrosis of the bronchial sub-mucosa is
apparent in areas adjacent to vacuolated epithelium in
50% of the animals examined (Fig. 7F, black arrow).
Unlike the clear airways observed 24 h after CO92ΔyopH
infection, at 48 h post-infection, there are exudates com-
posed of PMNs, macrophages, and sloughed epithelial
Figure 4 Pro-inflammatory cytokines in the BALF of infected mice. 6-8 week old female CD1 mice were infected with 2×104 CFU of either CO92 
or CO92ΔyopH. Mice were sacrificed at 24 h and 48 h post-infection and bronchoalveolar lavage was performed on their lungs. BALF was collected, 
filtered, and assayed by ELISA for the presence of TNF-α and IL-1β. Levels of TNF-α (A) and IL-1β (B) are significantly higher at 24 h post-infection in 
mice infected with Y. pestis CO92ΔyopH as compared to mice infected with wild-type CO92.  = mice infected with wild-type Y. pestis CO92,  = mice 
infected with Y. pestis CO92ΔyopH, *** p < 0.001, ** p < 0.01, * p < 0.05, non-parametric ANOVA, these data represent 8-12 samples per data point 
assayed in duplicate, and are from two independent experiments.Cantwell et al. BMC Immunology 2010, 11:29
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cells (Fig. 6F). However, bacteria were not evident in the
airways of any of the animals infected with CO92ΔyopH.
Altogether these data suggest that CO92ΔyopH induces a
robust inflammatory response prior to what is observed
with CO92 infection. Further, CO92ΔyopH causes signifi-
cant vacuolization of the bronchial epithelium that is only
occasionally observed during a CO92 infection.
Discussion
We investigated the effect of YopH deletion on the viru-
lence of Y. pestis using a murine model of primary pneu-
monic plague. YopH, a type-three secretion system
effector protein, is a protein tyrosine phosphatase that is
involved in inhibiting phagocytosis [14,17], as well as
blocking the PI3-kinase pathway [15]. Investigators have
studied the effect of YopH deletion using multiple species
of Yersinia, including Y. pestis yopH pgm double mutants
utilizing several routes of infection [11,15,17-21]. To date
most yopH mutants tested have exhibited decreased viru-
lence and interestingly, lung infections of Balb/c mice
with a yopH mutant of the closely related Yersinia
pseudotuberculosis resulted in a strong attenuation phe-
Figure 5 Antibody mediated depletion of TNF-α or IL-1β enhances virulence of CO92ΔyopH. CD-1 mice were treated with cytokine depleting 
antibodies or isotype control antibodies 1 day prior to infection and then every third day for the course of the experiment. Animals were then infected 
IN with 2 X104 CFU of CO92 or CO92ΔyopH and monitored for survival for 10 days. A) Depletion of IL-1β has no effect. B) Depletion of TNF-α causes 
10% mortality. C) Depletion of both TNF-α and IL-1β has a synergistic effect leading to 30% mortality. D) Depletion of IL-1β during CO92 infection has 
no effect. E) Depletion of TNF-α during CO92 infection has no effect. Data is combined from two independent experiments with 10 mice per group.Cantwell et al. BMC Immunology 2010, 11:29
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notype [19]. However, this has never been tested in a
murine model of primary pneumonic plague using WT Y.
pestis strains.
The attenuation of CO92ΔyopH is due to the loss of the
protein because virulence can be restored when the
CO92ΔyopH mutant is complemented with a wild type
copy of the YopH gene. Further, it is the actual phos-
phatase activity of YopH that is required for virulence
since a CO92ΔyopH mutant complemented with a yopH
gene containing an enzymatic inactivating mutation
(C403A) is completely attenuated. This is an intriguing
finding suggesting that small molecule inhibitors of the
YopH phosphatase activity might be useful therapeutics
for the treatment of plague.
In addition to evaluating the virulence of CO92ΔyopH,
we examined the host response to pulmonary infection
by testing for differences in pro-inflammatory cytokines
expression and lung histopathology. We hypothesized
that there could be a host component that contributed to
the attenuation of the CO92ΔyopHmutant. It has been
observed by us and others that infection with Y. pestis
CO92 leads to a delayed inflammatory response, which
results in very high bacterial loads in the lungs, liver and
spleen, ultimately leading to the death of the host [4,5,26].
We speculated that alleviation of the anti-inflammatory
mechanisms of Y. pestis would provide protection for the
host.
In the absence of YopH, the host responds to the pres-
ence of Y. pestis with an early pro-inflammatory response,
namely, an increase in TNF-α and IL-1β in the BALF at
24 h post-infection, which diminishes in magnitude by 48
h post-infection. This is different than what is observed
with CO92 infection, where an inflammatory response is
not observed until 48 h post-infection [4]. In addition, the
kinetics of bacterial growth following an intranasal infec-
tion with CO92ΔyopH is different than the kinetics of
CO92 intranasal infection. First, CO92ΔyopH is able to
persist in the lungs of infected mice, although the bacte-
rial burdens observed are significantly lower than those
of CO92 at both at 24 h and 48 h post-infection. It
appears that the CO92ΔyopH is unable to propagate in
the lungs of the host, as demonstrated by the fact that the
amount of bacteria detected in the lungs remains approx-
imately the same at 24 h and 48 h post-infection. These
data are similar to what is observed with a pulmonary
infection with the Y. pseudotuberculosis yopH mutant
[19]. Additionally, CO92ΔyopH is unable to disseminate
from the site of infection to either the liver or spleen at 24
h, 48 h, 72 h, or 96 h post-infection. In contrast, infection
with wild-type CO92 results in dissemination and high
bacterial burdens in the liver and spleen at 48 h post-
infection, and the majority of the animals are dead by 72
h post-infection [4]. Viable CO92ΔyopH is cleared from
the host by 72 h post-infection being undetectable in the
lung, liver, or spleen of mice 72 h and 96 h post-infection
(data not shown). In light of these data, we hypothesize
that the early pro-inflammatory response observed dur-
ing infection with CO92ΔyopH is key in allowing the host
Figure 6 Mice lacking TNF-α are partially sensitive to CO92ΔyopH 
infection. B6129F2 control mice or B6;129S-Tnftm1Gkl/J (TNF-α-/-) mice 
were infected IN with 2 × 104 CFU of CO92 or CO92ΔyopH and then 
monitored for survival over a ten day period. A) TNF-α-/- mice are sen-
sitive to CO92ΔyopH infection. B) Both TNF-α-/- mice and control mice 
are sensitive to CO92 infection. Data was analyzed by log-rank analysis 
and significant comparisons indicated. Data is combined from two in-
dependent experiments with 5 mice per group.
Figure 7 Histopathology of pulmonary infection with CO92 or 
CO92ΔyopH.
CD1 mice were infected IN with 2 × 104 CFU of CO92 or CO92ΔyopH for 
24 or 48 hours. Representative 20× images of lungs are presented. A) 
Mouse mock infected for 24 hours with saline. B) Mouse infected with 
CO92 for 24 hours. C) Mouse infected with CO92ΔyopH for 24 hours 
with black arrow pointing out vacuolated bronchial epithelium. D) 
Mouse infected with CO92 for 48 hours. Black arrows denote robust 
neutrophilic inflammation, bacteria, and dead cells. E) 100× image of 
free bacteria in the airways of mice infected with CO92 for 48 hours 
(black arrow). F-H) Mouse infected with CO92ΔyopH for 48 hrs. F) Vac-
uolization in conjunction with exudates denoted by the double black 
arrows and an area of sub-mucosal necrosis denoted by the single 
black arrow. G) Large infiltration of PMNs adjacent to bronchiole. Note 
that there are no bacteria evident at this time point. H) 100× image of 
infiltration of the bronchial epithelium with PMNs. Data is representa-
tive images of 8-10 mice per time point.Cantwell et al. BMC Immunology 2010, 11:29
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to adequately control the bacteria and prevent a fulmi-
nate infection.
Additional evidence for this conclusion lies in the dif-
ferences observed in the histopathology of lungs from
mice infected with either wild type CO92 or CO92ΔyopH
at both 24 h and 48 h post-infection. The lung histopa-
thology of these two infections is strikingly different and
provides some insight into the dissimilar courses that
these infections follow. At 24 hours post-infection with
wild-type Y. pestis, there are only subtle changes in the
lung tissue with very little tissue damage. Infection with
CO92ΔyopH  at this same time post-infection leads to
widespread vacuolization of bronchial epithelium and
infiltration of inflammatory cells. It is unclear what leads
to the vacuolization, but it is possible that the cyto-toxic
effects of YopE and YopO are amplified in the yopH
mutant [6,8,27]. After 48 hours of infection with CO92,
evidence of severe lung pathology is evident including
pulmonary consolidation and a heavy infiltration of
inflammatory cells comprised predominantly of PMNs.
In addition, free bacteria are readily observed throughout
the lung tissue. In CO92ΔyopH infection, at 48 h post-
infection, about 50% of mice exhibit large lesions with
PMNs, but strikingly, no bacteria are observed. This pro-
vides further evidence that an early inflammatory
response to infection with CO92ΔyopH might be protec-
tive, and contribute to the clearance of Y. pestis prior to
outgrowth and dissemination of the bacteria.
Other investigators recently observed that when innate
immunity and specifically inflammatory immune
responses are intact, infection with Y. pestis does not
cause severe disease. For example, Y. pestis modifies its
LOS when growing at 37°C, using a tetra-acylated lipid A,
which only weakly induces a pro-inflammatory response
in the host. At 21-27°C, Y. pseudotuberculosis produces a
hexa-acylated lipid A, the form of lipid A which is able to
elicit potent inflammatory responses from the host [28].
The tetra-acylated lipid A has poor Toll-like receptor 4
(TLR-4) stimulating activity and therefore does not elicit
the same robust pro-inflammatory response induced by
hexa-acylated lipid A [28]. When Montminy et al geneti-
cally modified Y. pestis to produce the more potent hexa-
acylated lipid A at 37°C, they found that mice did not
develop bubonic plague when infected subcutaneously
even at doses approaching 106 mean lethal doses [29].
These data indicate that the TLR-4 response is critical in
overcoming infection with Y. pestis and that by avoiding
this response through LPS modification, Y. pestis is able
to cause disease in the host [29]. A second study demon-
strating the importance of an active inflammatory
response early in Y. pestis infection showed that when
m i c e  w e r e  l a t e n t l y  i n f e c t e d  w i t h  g a m m a - h e r p e s  v i r u s
there is a significant increase in activated circulating
macrophages and the severity of subsequent infection
with fully virulent Y. pestis was decreased compared to
mice which were mock infected with virus [30]. Consis-
tent with the data presented in this study, TLR-4 signaling
and activated macrophages are capable of producing and
responding to IL-1β and TNF-α to fight against bacterial
infection.
YopH is a complex virulence factor that impacts many
aspects of the pathogenesis of Yersinia sp. Given that
YopH is a potent protein tyrosine phosphatase, it is well
suited to disrupting host signal transduction pathways. It
is interesting to note that the majority of evidence
obtained studying the enteropathogenic Yersinia suggests
that YopH acts to diminish integrin signaling following
invasin binding [7,12,17,31,32]. The result of this is that Y.
enterocolitica  and  Y. pseudotuberculosis are predomi-
nantly extracellular pathogens. In contrast, Y. pestis
CO92 does not express invasin [33], and is a facultative
intracellular pathogen but YopH is a required virulence
factor suggesting it has additional roles in Y. pestis patho-
genesis.
We hypothesize that the anti-host activities of YopH are
beneficial to the survival of Y. pestis within the mamma-
lian host and that YopH contributes to the virulence of
the organism by preventing an early pro-inflammatory
response at the site of infection; thereby allowing the bac-
teria to rapidly replicate in the organs of infected mice,
overwhelming and killing the host. YopH directly impacts
these key aspects of the pathogenesis of plague pneumo-
nia. However, given the number of potential host-path-
ways that could be targeted by YopH, it is likely that this
virulence factor impacts multiple aspects of Y. pestis
pathogenesis.
Conclusions
Pathogenic Yersinia have evolved numerous mechanisms
to survive in their hosts and many of the proteins that
support survival in the host are virulence factors. Many of
the most potent virulence factors are encoded on the 70
Kb virulence plasmid pCD-1 and several of them have
been shown to be critical for causing disease. Amongst
the essential plasmid-encoded virulence factors is YopH a
protein tyrosine phosphatase that has been shown to be
critical for the inhibition of invasion by the enteropatho-
genic yersiniae. Interestingly, Y. pestis is a facultative
intracellular pathogen that does not express the Inv pro-
tein suggesting that Y. pestis YopH plays additional roles
in the pathogenesis of this pathogen.
A mutation in yopH leads to severe attenuation of viru-
lence in mouse models of primary plague pneumonia. In
this study, our data suggests that YopH inhibits the pro-
duction of IL-1β and TNF-α during the first 24 hours
post-infection. The inhibition of IL-1β and TNF-α is a
critical step in the pathogenesis of infection because mice
deficient in these molecules are partially sensitive toCantwell et al. BMC Immunology 2010, 11:29
http://www.biomedcentral.com/1471-2172/11/29
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infection with the yopH mutant. Further, the YopH phos-
phatase activity is essential for virulence because mice
infected with the CO92ΔyopH strain complemented with
a wild type copy of the yopH gene succumb to infection
with kinetics similar to CO92 infection but complemen-
tation with the yopH-C403A  gene restores complete
attenuation. Altogether our data suggests that YopH plays




Yersinia pestis CO92, a biovar Orientalis strain recently
isolated from a case of pneumonic plague, was obtained
from the Select Agent Distribution Activity (SADA),
Centers for Disease Control and Prevention (CDC), Fort
Collins, CO. The strain was confirmed to contain the pig-
mentation (pgm) locus phenotypically by producing red
colonies on Congo red plates and by polymerase chain
reaction (PCR). The presence of the low calcium
response virulence plasmid (Lcr) was confirmed by PCR
of the lcrV, yopH, and yopJ genes. Virulence in mice was
confirmed as described below. The yopH deletion mutant
was created in Y. pestis strain CO92 using the suicide vec-
tor pSR47s [34], a derivative of pSR47 [35], as described
[18]. The yopH mutation was complemented by cloning
the CO92 yopH gene and 247bp of 5' UTR into the
pCR2.1 plasmid creating pAMC-1. Complemented
strains were shown to produce equivalent amounts of
YopH after in vitro induction of TTS as described [36].
The YopH-C403A active site mutant was produced on
the pAMC-1 plasmid background using the quick-change
method as we have previously described creating pAMC-
2 [37]. YopH was detected in the TCA precipitated cul-
ture supernatant and in whole cell extracts by immunob-
lot using a rabbit polyclonal anti-YopH antibody kindly
provided by James Bliska (SUNY Stony Brook).
Animal Infections
Six to eight-week old female out-bred CD1 mice (Charles
River Laboratories, Willmington, MA) were used for
most studies and processed as we have previously
described [4,18]. TNF-α deficient mice (B6;129S-
Tnftm1Gkl/J stock #003008) and controls (B6129SF2/J
stock #101045) were obtained from Jackson Laboratory
(Bar Harbor, ME) and used at 6 weeks of age. Fully viru-
lent  Yersinia pestis strain CO92 or CO92ΔyopH  was
grown for 20 hours at 28°C in Heart Infusion broth (US
Biological, Swampscott, MA) supplemented with 0.2%
xylose. Cultures were then harvested and washed once
with sterile PBS, then diluted in endotoxin-free PBS to
approximately 106 bacteria/mL. Bacterial concentrations
were verified by enumerating colony forming units (CFU)
on Congo red plates. Mice were anesthetized by intrap-
eritoneal injection of 0.5 mL Avertin (20 mg/mL in PBS,
2-2-2 Tribromoethanol, Sigma, St. Louis, MO) and then
intranasally infected with 20 uL of inoculums (10 uL/
nare). Intradermal infections were performed by injec-
tion of the appropriate dilution of culture in 50 μl volume
into the left ear using an insulin syringe as described [38].
Actual CFU's for individual experiments were deter-
mined by plating serial dilutions of the inoculums and are
reported in the subsequent text and graphics. Mice were
euthanized by overdose of isoflurane (Iso-Thesia, Vetus
Animal Health, Burns Veterinary Supply, Inc., Westbury,
NY) and then cervical dislocation at 24, 48, 72, or 96
hours after infection as indicated. For mice used to deter-
mine the virulence of CO92ΔyopH, mice were inoculated
with up to 2×107 CFU/mouse, and survival was moni-
tored daily over a period of 10-14 days depending on
experimental design. All experiments using Y. pestis were
performed at Biosafety Level 3, in accordance with
approved Institutional Biosafety Committee and Institu-
tional Animal Care and Use Committee protocols.
Bacterial Burden
The bacterial burden in target organs of mice infected
with either Y. pestis CO92 or CO92ΔyopH  was deter-
mined as previously described [39]. Briefly, lungs, liver,
and spleen were harvested at the indicated times and
weighed prior to homogenization. Tissue homogenates
were then diluted in PBS and dilutions were plated on
Congo red plates. Bacterial growth was evaluated after 72
hours incubation at 28°C. Results are presented as CFU/
gram of tissue and representative data from two indepen-
dent experiments with at least six mice per data point is
shown.
In vivo Cytokine Depletion
IL-1β and TNF-α were depleted by antibody-mediated
ablation as we described previously [22]. Briefly, CD1
mice were injected IP with 0.25 mg of rat anti-mTNF-α
(clone MP6-XT22, e-Biosciences), hamster anti-mIL-1β
(clone B122, e-Biosciences) or a mixture of 0.25 mg of
both antibodies one day prior to infection with CO92 or
CO92ΔyopH and then every third day until the end of the
experiment. Control animals received an equivalent con-
centration of isotype-matched irrelevant rat or hamster
IgG respectively. Mice were then monitored daily for sur-
v i v a l .  D a t a  r e p r e s e n t s  e x p e r i m e n t s  w i t h  1 0  m i c e  p e r
group.
Bronchoalveolar lavage
Mice were euthanized and a 1 cm longitudinal incision
was made to expose the trachea. Bronchoalveolar lavage
(BAL) was performed by catheterizing the trachea using
18 gauge catheters (Beckton, Dickinson Infusion Therapy
Systems, Inc., Sandy, UT). Each mouse was lavaged withCantwell et al. BMC Immunology 2010, 11:29
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three 1 mL aliquots of PBS with protease inhibitors (pep-
statin, PMSF, aprotinin, leupeptin, Sigma, St. Louis, MO).
BAL fluids (BALF) were placed immediately on ice, fil-
tered with a 0.2 μm syringe filter (SFCA, Fisher Scientific,
Pittsburg, PA), and stored at -80°C for future analysis.
The results are representative of two independent experi-
ments with four to six animals per bacterial strain and
time point.
ELISA
BALF samples or tissue culture supernatants were diluted
as appropriate and used in ELISA assays for mouse TNFα
and IL-1β (BD Biosciences Pharmingen, San Diego, CA)
following the manufacturers instructions. Eight to twelve
samples per data point were used in the assays; each sam-
ple was assayed in duplicate.
Histopathology
Following IN infection, the lungs were harvested at the
indicated times and their gross appearance was evaluated
at necropsy. At least ten animals per data point were
examined. Tissues were fixed in 10 ml of 10% neutral
buffered formalin (NBF). Formalin-fixed tissues were
then embedded in paraffin and 3-4 μm sections were cut
a n d  p l a c e d  o n  s l i d e s .  T h e  t i s s u e  s e c t i o n s  w e r e  t h e n
stained with hematoxylin and eosin (H&E). Tissues were
examined from at least eight mice per time point and
evaluated in blind fashion for inflammatory cell infiltra-
tion, bacterial colonization, and presence of inflamma-
tory exudates in airways, edema, necrosis, hemorrhage,
and fibrin. Images were captured digitally on a Zeiss
Axioscope 2 microscope equipped with a digital camera.
Images were processed using the Axiovision V.4 suite of
software (Carl Zeiss, Inc., Thornwood, NY).
Statistical analysis
All results were expressed as the mean ± SEM. Statistical
differences were determined using either a two-tailed
Student's t test or Mann-Whitney non-parametric test as
indicated using GraphPad In-Stat3 (GraphPad Software).
Survival data was analyzed by log-rank analysis where
possible. A value for p < 0.05 was considered significant.
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